lamotrigine has been researched along with Adolescent Myoclonic Epilepsy in 23 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Plasma homocysteine, folate, vitamins B12 and B6 (pyridoxal phosphate), and red cell folate levels were measured in samples while she was receiving folic acid therapy for 1 month during the second trimester of pregnancy." | 3.73 | Antiepileptic drugs: a case report in a pregnancy with a neural tube defect. ( Bongain, A; Candito, M; Guéant, JL; Naimi, M; Van Obberghen, E, 2006) |
| "Myoclonic jerks are frequently the debut symptom, while tonic-clonic seizures appear later on." | 2.48 | [Juvenile myoclonic epilepsy]. ( Markhus, R; Nakken, KO; Selmer, KK; Syvertsen, MR, 2012) |
| "Juvenile myoclonic epilepsy is a common idiopathic generalized epileptic syndrome that includes generalized myoclonic seizures and commonly generalized tonic-clonic and generalized absence seizures." | 2.45 | The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent? ( Abou-Khalil, B; Montouris, G, 2009) |
| "Drug treatment of juvenile myoclonic epilepsy (JME) is mainly based on clinical experience and prospective and retrospective studies, with little evidence from randomized clinical trials." | 2.44 | Treatment of juvenile myoclonic epilepsy. ( Auvin, S, 2008) |
| "This study aimed to evaluate antiseizure medication (ASM) use in patients with JME." | 1.72 | Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020. ( Aydın, K; Cansu, A; Esenülkü, G; Haspolat, Ş; İnce, T; Kılıç, B; Okuyaz, Ç; Polat, BG; Serdaroğlu, A; Serdaroğlu, E; Tekgül, H; Topçu, Y, 2022) |
| "Under lamotrigine, seizure aggravation was observed in 15 patients (two patients during levetiracetam, one patient during zonisamide, none during phenobarbital and valproic acid)." | 1.62 | Risk factors of paradoxical reactions to anti-seizure medication in genetic generalized epilepsy. ( Beier, CP; Gesche, J; Hjalgrim, H; Rubboli, G, 2021) |
| "Patients with juvenile myoclonic epilepsy (JME) may have uncontrolled seizures." | 1.51 | Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy. ( Baftiu, A; Enger, U; Fløgstad, I; Johannessen Landmark, C; Johannessen, SI; Koht, J; Syvertsen, M, 2019) |
| "Juvenile myoclonic epilepsy is often regarded as a benign epileptic syndrome, but in this setting, half of the individuals with JME have refractory epilepsy with only about a quarter of those seizure-free in the previous year." | 1.48 | Juvenile myoclonic epilepsy refractory to treatment in a tertiary referral center. ( Cação, G; Mannan, S; Parra, J; Sander, JW; Sisodiya, SM, 2018) |
| "JME patients without generalized tonic clonic seizures (GTCS) responded better to LTG (P = 0." | 1.37 | Outcome of lamotrigine treatment in juvenile myoclonic epilepsy. ( Ben-Zeev, B; Blatt, I; Bodenstein-Sachar, H; Chapman, J; Gandelman-Marton, R, 2011) |
| "When lamotrigine was restarted 2 weeks later she developed similar but more severe symptoms which resolved on stopping lamotrigine." | 1.35 | Anticonvulsant hypersensitivity syndrome presenting as aseptic meningitis. ( Bazaz, R; Lily, O; Maniyar, F; Rooney, C, 2009) |
| "Lamotrigine is an anti-epileptic drug considered as a first-line therapy in idiopathic generalised epilepsy." | 1.33 | [Exacerbation of tonicoclonic seizures in a juvenile myoclonic epileptic taking lamotrigine]. ( Guillon, B; Maiga, Y; Nogues, B, 2006) |
| "We studied 14 patients with juvenile myoclonic epilepsy (JME), 19 patients with refractory localization-related epilepsy (RLE) and 20 healthy volunteers who were matched for age and sex." | 1.32 | Uptake of GABA and activity of GABA-transaminase in platelets from epileptic patients. ( Keränen, T; Peltola, J; Rainesalo, S; Saransaari, P, 2003) |
| "Most cases of toxic epidermal necrolysis are drug induced." | 1.32 | Suspected lamotrigine-induced toxic epidermal necrolysis. ( Demiralay, E; Kilinç, M; Söğüt, A; Söğüt, AG; Uzar, H; Yilmaz, A, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (52.17) | 29.6817 |
| 2010's | 8 (34.78) | 24.3611 |
| 2020's | 3 (13.04) | 2.80 |
| Authors | Studies |
|---|---|
| Kılıç, B | 1 |
| Serdaroğlu, E | 1 |
| Polat, BG | 1 |
| İnce, T | 1 |
| Esenülkü, G | 1 |
| Topçu, Y | 1 |
| Serdaroğlu, A | 1 |
| Haspolat, Ş | 1 |
| Tekgül, H | 1 |
| Okuyaz, Ç | 1 |
| Cansu, A | 1 |
| Aydın, K | 1 |
| Gesche, J | 1 |
| Hjalgrim, H | 1 |
| Rubboli, G | 1 |
| Beier, CP | 1 |
| Milano, C | 1 |
| Turco, F | 1 |
| Pizzanelli, C | 1 |
| Bonanni, E | 1 |
| Siciliano, G | 1 |
| Fornai, F | 1 |
| Giorgi, FS | 1 |
| Cação, G | 1 |
| Parra, J | 1 |
| Mannan, S | 1 |
| Sisodiya, SM | 1 |
| Sander, JW | 1 |
| Johannessen Landmark, C | 2 |
| Fløgstad, I | 2 |
| Baftiu, A | 2 |
| Syvertsen, M | 2 |
| Enger, U | 2 |
| Koht, J | 2 |
| Johannessen, SI | 2 |
| Papadavid, E | 1 |
| Evangelia, P | 1 |
| Panayiotides, I | 1 |
| Ioannis, P | 1 |
| Makris, M | 1 |
| Michael, M | 1 |
| Giatrakou, S | 1 |
| Sophia, G | 1 |
| Dalamaga, M | 1 |
| Maria, D | 1 |
| Stavrianeas, N | 2 |
| Rigopoulos, D | 1 |
| Dimitrios, R | 1 |
| Machado, RA | 1 |
| García, VF | 1 |
| Astencio, AG | 1 |
| Cuartas, VB | 1 |
| Chowdhury, A | 1 |
| Brodie, MJ | 1 |
| Auvin, S | 1 |
| Maniyar, F | 1 |
| Rooney, C | 1 |
| Lily, O | 1 |
| Bazaz, R | 1 |
| Montouris, G | 1 |
| Abou-Khalil, B | 1 |
| Bodenstein-Sachar, H | 1 |
| Gandelman-Marton, R | 1 |
| Ben-Zeev, B | 1 |
| Chapman, J | 1 |
| Blatt, I | 1 |
| Syvertsen, MR | 1 |
| Markhus, R | 1 |
| Selmer, KK | 1 |
| Nakken, KO | 1 |
| Rainesalo, S | 1 |
| Saransaari, P | 1 |
| Peltola, J | 1 |
| Keränen, T | 1 |
| Söğüt, A | 1 |
| Yilmaz, A | 1 |
| Kilinç, M | 1 |
| Söğüt, AG | 1 |
| Demiralay, E | 1 |
| Uzar, H | 1 |
| Morris, GL | 1 |
| Hammer, AE | 1 |
| Kustra, RP | 1 |
| Messenheimer, JA | 1 |
| Candito, M | 1 |
| Guéant, JL | 1 |
| Naimi, M | 1 |
| Bongain, A | 1 |
| Van Obberghen, E | 1 |
| Maiga, Y | 1 |
| Nogues, B | 1 |
| Guillon, B | 1 |
| Plattner, B | 1 |
| Pahs, G | 1 |
| Kindler, J | 1 |
| Williams, RP | 1 |
| Hall, RE | 1 |
| Mayer, H | 1 |
| Steiner, H | 1 |
| Feucht, M | 1 |
| Alfradique, I | 1 |
| Vasconcelos, MM | 1 |
| Biraben, A | 1 |
| Allain, H | 1 |
| Scarabin, JM | 1 |
| Schück, S | 1 |
| Edan, G | 1 |
| Carrazana, EJ | 1 |
| Wheeler, SD | 1 |
4 reviews available for lamotrigine and Adolescent Myoclonic Epilepsy
| Article | Year |
|---|---|
Treatment of juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Female; Humans; Infant; Lamotrigine; Le | 2008 |
The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
Topics: Anticonvulsants; Congenital Abnormalities; Delayed-Action Preparations; Drug Design; Epilepsy, Gener | 2009 |
[Juvenile myoclonic epilepsy].
Topics: Adolescent; Anticonvulsants; Diagnosis, Differential; Electroencephalography; Female; Humans; Lamotr | 2012 |
Juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Child; Diagnosis, Differential; Electroencephalography; Humans; | 2007 |
2 trials available for lamotrigine and Adolescent Myoclonic Epilepsy
| Article | Year |
|---|---|
Efficacy and tolerability of lamotrigine in juvenile myoclonic epilepsy in adults: a prospective, unblinded randomized controlled trial.
Topics: Adolescent; Adult; Anticonvulsants; Female; Humans; Lamotrigine; Male; Middle Aged; Myoclonic Epilep | 2013 |
Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study.
Topics: Adolescent; Anticonvulsants; Child; Drug Evaluation; Humans; Lamotrigine; Myoclonic Epilepsy, Juveni | 2004 |
17 other studies available for lamotrigine and Adolescent Myoclonic Epilepsy
| Article | Year |
|---|---|
Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020.
Topics: Adolescent; Anticonvulsants; Child; Female; Humans; Lamotrigine; Levetiracetam; Male; Myoclonic Epil | 2022 |
Risk factors of paradoxical reactions to anti-seizure medication in genetic generalized epilepsy.
Topics: Adult; Anticonvulsants; Epilepsy, Generalized; Humans; Lamotrigine; Levetiracetam; Myoclonic Epileps | 2021 |
Response to levetiracetam or lamotrigine in subjects with Juvenile Myoclonic Epilepsy previously treated with valproic acid: A single center retrospective study.
Topics: Anticonvulsants; Female; Humans; Lamotrigine; Levetiracetam; Myoclonic Epilepsy, Juvenile; Retrospec | 2021 |
Juvenile myoclonic epilepsy refractory to treatment in a tertiary referral center.
Topics: Adolescent; Adult; Anticonvulsants; Child; Drug Resistant Epilepsy; Electroencephalography; Female; | 2018 |
Long-term follow-up with therapeutic drug monitoring of antiepileptic drugs in patients with juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Drug Monitoring; Female; Follow-Up Studies; Humans; Lamotrigine; | 2019 |
Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Cohort Studies; Female; Humans; Lamotrigine; Levetiracetam; Male | 2019 |
Pityriasis rosea-like eruption associated with lamotrigine.
Topics: Adult; Anticonvulsants; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Lamotrigine; Myocloni | 2013 |
Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
Topics: Adolescent; Adult; Anticonvulsants; Child; Comorbidity; Drug Resistant Epilepsy; Female; Follow-Up S | 2016 |
Anticonvulsant hypersensitivity syndrome presenting as aseptic meningitis.
Topics: Anti-Bacterial Agents; Anticonvulsants; Drug Administration Schedule; Drug-Related Side Effects and | 2009 |
Outcome of lamotrigine treatment in juvenile myoclonic epilepsy.
Topics: Adolescent; Anticonvulsants; Child; Female; Humans; Lamotrigine; Male; Myoclonic Epilepsy, Juvenile; | 2011 |
Uptake of GABA and activity of GABA-transaminase in platelets from epileptic patients.
Topics: 4-Aminobutyrate Transaminase; Adult; Anticonvulsants; Blood Platelets; Case-Control Studies; Dose-Re | 2003 |
Suspected lamotrigine-induced toxic epidermal necrolysis.
Topics: Adult; Anticonvulsants; Drug Therapy, Combination; Female; Humans; Lamotrigine; Myoclonic Epilepsy, | 2003 |
Antiepileptic drugs: a case report in a pregnancy with a neural tube defect.
Topics: Adult; Anticonvulsants; Female; Folic Acid; Homocysteine; Humans; Lamotrigine; Myoclonic Epilepsy, J | 2006 |
[Exacerbation of tonicoclonic seizures in a juvenile myoclonic epileptic taking lamotrigine].
Topics: Adult; Anticonvulsants; Electroencephalography; Epilepsy, Tonic-Clonic; Humans; Lamotrigine; Male; M | 2006 |
Juvenile myoclonic epilepsy: a benign disorder? Personality traits and psychiatric symptoms.
Topics: Adolescent; Adult; Anticonvulsants; Child; Ethosuximide; Female; Fructose; Humans; Lamotrigine; Leve | 2007 |
Exacerbation of juvenile myoclonic epilepsy with lamotrigine.
Topics: Adolescent; Adult; Anticonvulsants; Female; Humans; Lamotrigine; Male; Myoclonic Epilepsy, Juvenile; | 2000 |
Exacerbation of juvenile myoclonic epilepsy with lamotrigine.
Topics: Adolescent; Adult; Anticonvulsants; Female; Humans; Lamotrigine; Male; Middle Aged; Myoclonic Epilep | 2001 |